614 results on '"Pharmaceutical industry -- Health aspects -- Research"'
Search Results
202. New Bacterial Infections and Mycoses Findings from Pontificia Universidade Catolica do Parana Described (Evaluation of in vitro activity of ceftolozane-tazobactam against recent clinical bacterial isolates from Brazil - the EM200 study)
203. Study Results from Johns Hopkins University Update Understanding of Non-Small Cell Lung Cancer (Principles of Immunotherapy in Non-Small Cell Lung Cancer)
204. Reports on Breast Cancer from University of California Los Angeles (UCLA) Provide New Insights [Potent Cell-cycle Inhibition and Upregulation of Immune Response With Abemaciclib and Anastrozole In Neomonarch, Phase Ii Neoadjuvant Study In ...]
205. Findings on Gram-Negative Bacterial Infections Reported by Investigators at National Cheng Kung University Hospital [In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the ...]
206. Researchers at University of Texas Southwestern Medical Center Detail Findings in Hepatitis C Virus (Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment)
207. Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days
208. New COVID-19 Findings from Nara Medical University Described (Transition of Antibody Titers After Sars-cov-2 Mrna Vaccination In Japanese Healthcare Workers)
209. Researchers from Brown University Describe Findings in Cryptococcosis (Cutaneous Sporothrix Globosa Infection Mimicking Cryptococcosis In a Patient With History of Kidney Transplant)
210. Investigators at University Hospital Zurich Detail Findings in Biomarkers (New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of Ph-sensing Receptor Gpr4)
211. Study Results from University of California Irvine Update Understanding of Veterans (Serum Creatinine-to-cystatin-c Ratio As a Potential Muscle Mass Surrogate and Racial Differences In Mortality)
212. Investigators at Nishtar Medical University Report Findings in COVID-19 (Administration of Sinopharm Covid-19 Vaccine In Cancer Patients)
213. New Findings in Male Kidney Diseases and Conditions Described from German Heart Center Berlin (Cardiac Surgery - Related Acute Kidney Injury _ Risk Factors, Clinical Course, Management Suggestions)
214. New Inflammatory Bowel Disease Findings from Regeneron Pharmaceuticals Inc. Reported (Regulatory T Cells As a Therapeutic Approach for Inflammatory Bowel Disease)
215. Research Conducted at Tohoku Medical and Pharmaceutical University Has Updated Our Knowledge about COVID-19 (Progression of Hemolysis In a Patient With Hereditary Spherocytosis After the Second Dose of Covid-19 Mrna Vaccine)
216. Research Conducted at Regeneron Pharmaceuticals Inc. Has Provided New Information about COVID-19 (Efficacy and Safety of a Single Dose of Casirivimab and Imdevimab for the Prevention of Covid-19 Over an 8-month Period: a Randomised, ...)
217. Studies from Pfizer Update Current Data on COVID-19 (Generation of a Veroe6 Pgp Gene Knock Out Cell Line and Its Use In Sars-cov-2 Antiviral Study)
218. Researchers from King Chulalongkorn Memorial Hospital Report New Studies and Findings in the Area of COVID-19 [Short-term Immune Response After Inactivated Sars-cov-2 (Coronavac?, Sinovac) and Chadox1 Ncov-19 (Vaxzevria?, Oxford-astrazeneca) ...]
219. NOVA Southeastern University Reports Findings in COVID-19 (A Comprehensive Review of Sars-cov-2 Vaccines: Pfizer, Moderna & Johnson & Johnson) (A Comprehensive Review of Sars-cov-2 Vaccines: Pfizer, Moderna & Johnson & Johnson)
220. Findings from Hashemite University Broaden Understanding of COVID-19 (Humoral Immune Response To Covid-19 Infection or Vaccination Among Celiac Disease Patients) (Humoral Immune Response To Covid-19 Infection or Vaccination Among Celiac Disease ...)
221. Research Data from University of California Santa Barbara Update Understanding of Sustainability Research (A Sustainable Synthesis of the Sars-cov-2 M-pro Inhibitor Nirmatrelvir, the Active Ingredient In Paxlovid) (A Sustainable Synthesis of ...)
222. Findings from National University of Colombia Broaden Understanding of Oropouche Virus (Oropouche Virus As an Emerging Cause of Acute Febrile Illness In Colombia) (Oropouche Virus As an Emerging Cause of Acute Febrile Illness In Colombia)
223. Researchers from Roche Diagnostics GmbH Provide Details of New Studies and Findings in the Area of COVID-19 [Aerosol Formation During Processing of Potentially Infectious Samples On Roche Immunochemistry Analyzers (Cobas E Analyzers) and In an ...] [
224. Omicron Infections Seem to Be Milder, Three Research Teams Report
225. Vaccinate five- to 11-year-olds to protect UK schools, scientists say; Call comes amid concerns that spread of Covid Omicron variant could disrupt education in new yearCoronavirus -- latest updatesSee all our coronavirus coverage
226. Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out
227. Pfizer Covid jab '90% effective against hospitalisation for at least 6 months'; Study shows protection against severe illness stays high, but scientists say boosters key to stopping spread of infection
228. Research at Ernest Mario School of Pharmacy finds that antiviral drug can treat coronavirus
229. Protection against infection offered by fourth Covid-19 vaccine dose wanes quickly, Israeli study finds
230. New COVID-19 Data Have Been Reported by Researchers at AstraZeneca [Durability of Protection and Immunogenicity of Azd1222 (Chadox1 Ncov-19) Covid-19 Vaccine Over 6 Months]
231. Findings on Cancer Reported by Investigators at National and Kapodistrian University of Athens (Y Programmed Cell Death Protein 1 Axis Inhibition In Viral Infections: Clinical Data and Therapeutic Opportunities)
232. Study Data from Oita Prefectural Hospital Update Understanding of COVID-19 [Acute Asthma Exacerbation Due To the Sars-cov-2 Vaccine (Pfizer-biontech Bnt162b2 Messenger Rna Covid-19 Vaccine [Comirnaty ®])]
233. Researchers from Harvard T.H. Chan School of Public Health Provide Details of New Studies and Findings in the Area of COVID-19 (Leveraging Serosurveillance and Postmortem Surveillance To Quantify the Impact of Coronavirus Disease 2019 In Africa)
234. Findings from Pfizer Yields New Data on COVID-19 (Safety and Efficacy of a Third Dose of Bnt162b2 Covid-19 Vaccine)
235. Researchers from University of California Los Angeles (UCLA) Provide Details of New Studies and Findings in the Area of Type 2 Diabetes (Living With Chronic Kidney Disease and Type 2 Diabetes Mellitus: the Patient and Clinician Perspective)
236. Findings on Human Herpesvirus 8 Discussed by Investigators at University of Zurich (Natural Killer Cell Responses To Human Oncogenic Gamma-herpesvirus Infections)
237. New Findings Reported from University of Texas MD Anderson Cancer Center Describe Advances in Hepatitis C Virus (Serologic Versus Molecular Testing for Screening for Hepatitis C Virus Infection In Patients With Hematologic Malignancies)
238. A 'dream vaccine' that can fight all coronaviruses; 'Eureka moment' as inoculated Sars survivors develop high antibody levels
239. Pfizer vaccine effectiveness declines faster than AstraZeneca, study shows; Researchers said that jabs still remain the most effective way to ensure protection against the Delta variant
240. Covishield offers 93% protection against COVID-19, reduces mortality rate by 98%: Study
241. New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR(r) Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy
242. KEY ANTIVIRAL TREATMENT FOR COVID-19 STILL EFFECTIVE DESPITE RESISTANCE FEARS
243. DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients
244. Pfizer COVID-19 vaccine 82 pct effective among most recovered patients: Israeli study
245. Pfizer-BioNTech COVID-19 booster improves vaccine effectiveness, study finds
246. Three New Studies Confirm Power of Booster Shots Against Omicron
247. STUDY FINDS FEWER BREAKTHROUGH COVID-19 INFECTIONS, LOWER RISK OF HOSPITALIZATION IN THOSE WHO RECEIVED MODERNA VACCINE COMPARED TO PFIZER--BIONTECH
248. Fourth vaccine dose boosts antibodies, researchers say, but likely not enough to prevent Omicron breakthrough infections
249. Prior Covid infection helps T Cells offer high protection against omicron; New study emphasises the importance of T helper and T killer cells in protecting against severe death and disease
250. NO OMICRON IMMUNITY WITHOUT BOOSTER, STUDY FINDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.